Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Vivax malaria relapses frequently even in low-transmission settings. Chloroquine delays but does not prevent recurrences. Adding primaquine to a slowly eliminated schizonticide significantly reduces recurrences and improves hematocrit, but this advantage is offset by hemolysis in G6PD-deficient females.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In Ethiopia, the treatment failure rate decreased from 5.6% with CQ to 0.75% with CQ–PQ [32], and studies in Thailand and Afghanistan also reported lower recurrence rates with CQ–PQ compared to CQ alone [36, 37].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Trade Report 2017: Trade, Technology and Jobs
World Trade Organization (2017) · World Trade Report · doi:10.30875/50d27d62-en · Cited by 212
Carrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001398 · Cited by 185 · cited 1×
“Malaria transmission in this tropical mountainous region is low and seasonal [6, 7].”
BackgroundSelf-citationMalaria ecology along the Thailand-Myanmar border.
Parker, D. M., Carrara, V. I., Pukrittayakamee, S., McGready, R., & Nosten, F. H. (2015) · Malaria Journal · doi:10.1186/s12936-015-0921-y · Cited by 142 · cited 1×
“Malaria transmission in this tropical mountainous region is low and seasonal [6, 7].”
BackgroundSelf-citation
Research works printed but not linked: 22
- Whorton, 1947, The Chesson strain of Plasmodium vivax malaria; factors influencing the incubation period, J Infect Dis, 80, 223, 10.1093/infdis/80.3.223 · doi:10.1093/infdis/80.3.223
- White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar J, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
- Commons, 2017, The vivax surveyor: online mapping database for Plasmodium vivax clinical trials, Int J Parasitol Drugs Drug Resist, 7, 181, 10.1016/j.ijpddr.2017.03.003 · DOI
- Pukrittayakamee, 2000, Therapeutic responses to different antimalarial drugs in vivax malaria, Antimicrob Agents Chemother, 44, 1680, 10.1128/AAC.44.6.1680-1685.2000 · DOI · Paper page
- Baird, 1997, Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels, Am J Trop Med Hyg, 56, 621, 10.4269/ajtmh.1997.56.621 · DOI · Paper page
- Russell, 2003, Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic, Antimicrob Agents Chemother, 47, 170, 10.1128/AAC.47.1.170-173.2003 · DOI
- Nuchprayoon, 2008, Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar, J Hum Genet, 53, 48, 10.1007/s10038-007-0217-3 · DOI
- Price, 2001, Factors contributing to anemia after uncomplicated falciparum malaria, Am J Trop Med Hyg, 65, 614, 10.4269/ajtmh.2001.65.614 · DOI · Paper page
- Sagara, 2014, Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data, Malar J, 13, 293, 10.1186/1475-2875-13-293 · DOI
- Luxemburger, 1999, Treatment of vivax malaria on the western border of Thailand, Trans R Soc Trop Med Hyg, 93, 433, 10.1016/S0035-9203(99)90149-9 · DOI
- Phyo, 2011, Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial, Clin Infect Dis, 53, 977, 10.1093/cid/cir631 · DOI · Paper page
- Most, 1963, Clinical trials of anti-malarial drugs, 525
- Sutanto, 2013, Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia, Antimicrob Agents Chemother, 57, 1128, 10.1128/AAC.01879-12 · DOI
- Nelwan, 2015, Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia, BMC Med, 13, 294, 10.1186/s12916-015-0535-9 · DOI
- Betuela, 2012, Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1–5 years of age, J Infect Dis, 206, 1771, 10.1093/infdis/jis580 · DOI · Paper page
- Pukrittayakamee, 1994, Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria, J Infect Dis, 169, 932, 10.1093/infdis/169.4.932 · DOI
- Pybus, 2013, The metabolism of primaquine to its active metabolite is dependent on CYP 2D6, Malar J, 12, 212, 10.1186/1475-2875-12-212 · DOI · Paper page
- St Jean, 2016, Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the phase 2b DETECTIVE trial, Malar J, 15, 97, 10.1186/s12936-016-1145-5 · DOI
- Bickerton-Blackburn, 1948, Observations on the development of resistance to vivax malaria, Trans R Soc Trop Med Hyg, 42, 117, 10.1016/0035-9203(48)90020-0 · doi:10.1016/0035-9203(48)90020-0
- Chu, 2017, Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens, PLoS Med, 14, e1002224, 10.1371/journal.pmed.1002224 · DOI · Paper page
- Tjitra, 2008, Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia, PLoS Med, 5, e128, 10.1371/journal.pmed.0050128 · DOI · Paper page
- Genton, 2008, Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea, PLoS Med, 5, e127, 10.1371/journal.pmed.0050127 · DOI · Paper page
Cited by
Siegel, S. V., Trimarsanto, H., Amato, R., Murie, K., Taylor, A. R., Sutanto, E., Kleinecke, M., Whitton, G., Watson, J. A., Imwong, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51015-3 · Cited by 30
Self-citationChu, C. S., Carrara, V. I., Parker, D. M., Proux, S., Charunwatthana, P., McGready, R., & Nosten, F. (2020) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0496 · Cited by 13
Self-citationGetu, E., Biruksew, A., Eshetu, T., Abamecha, A., Assefa, D. G., Mohammed, H., Wuletaw, Y., Tasew, G., Tollera, G., Hailu, M., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05446-y · Cited by 4
Metadata
- Authors
- Chu, C. S., Phyo, A. P., Lwin, K. M., Win, H. H., San, T., Aung, A. A., Raksapraidee, R., Carrara, V. I., Bancone, G., Watson, J., Moore, K. A., Wiladphaingern, J., Proux, S., Sriprawat, K., Winterberg, M., Cheah, P. Y., Chue, A. L., Tarning, J., Imwong, M., Nosten, F., & White, N. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-08
- Volume
- 67
- Issue
- 10
- Pages
- 1543-1549
- ISSN
- 1058-4838
- 1537-6591
- Cited by
- 64
- References
- 3
- Language
- en
- Funders
- Wellcome Trust (089179/Z/09/Z)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria. https://app.cochat.ai/papers/10.1093/cid/ciy319
- The paper
- Chu, C. S., Phyo, A. P., Lwin, K. M., Win, H. H., San, T., Aung, A. A., Raksapraidee, R., Carrara, V. I., Bancone, G., Watson, J., Moore, K. A., Wiladphaingern, J., Proux, S., Sriprawat, K., Winterberg, M., Cheah, P. Y., Chue, A. L., Tarning, J., Imwong, M., . . . White, N. J. (2018). Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciy319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.